Research Topics
| S R EarnshawSummaryAffiliation: RTI International Country: USA Publications
| Collaborators |
Detail Information
Publications
Optimal allocation of resources across four interventions for type 2 diabetesStephanie R Earnshaw
RTI Health Solutions, RTI, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709, USA
Med Decis Making 22:S80-91. 2002..CONCLUSIONS: A resource allocation model identifies trade-offs involved when imposing budget and equity constraints on care for individuals with newly diagnosed diabetes...- Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonatesS R Earnshaw
RTI Health Solutions, 3040 Cornwallis Road, P O Box 12194, Research Triangle Park, NC 27709, USA
Curr Med Res Opin 23:2517-29. 2007..An oral, less frequent administration bisphosphonate provides an opportunity to improve persistence, a parameter not well modeled in previous cost-effectiveness analyses of osteoporosis therapies... 
Lifetime cost-effectiveness of calcineurin inhibitor withdrawal after de novo renal transplantationStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, North Carolina, USA
J Am Soc Nephrol 19:1807-16. 2008....
Model-based cost-effectiveness analyses for prostate cancer chemoprevention : a review and summary of challengesStephanie R Earnshaw
RTI Health Solutions, 3040 Cornwallis Road, Post Office Box 12194, Research Triangle Park, NC 27709 2194, USA
Pharmacoeconomics 31:289-304. 2013..This understanding allows us to provide recommendations for using decision modelling in future economic evaluations of chemoprevention for PCa...- Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in CanadaStephanie R Earnshaw
RTI Health Solutions, 200 Park Offices Drive, Research Triangle Park, NC 27709, USA
BMC Infect Dis 12:101. 2012..We examined public health and economic impacts of a PCV10 and PCV13 pediatric national immunization programs (NIPs) in Canada... - Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United kingdomStephanie R Earnshaw
RTI Health Solutions, 200 Park Offices Dr, Research Triangle Park, NC 27709, USA
Clin Ther 34:1544-58. 2012..However, trade-offs in terms of administration time and cost may affect the value of using these diagnostic studies... - Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysisStephanie R Earnshaw
RTI Health Solutions, NC 27709, USA
Stroke 40:1710-20. 2009..We examined the cost-effectiveness of adding penumbral-based MRI to usual computed tomography (CT)-based methods to identify patients for IV tPA treatment... - Cost effectiveness of glatiramer acetate and natalizumab in relapsing-remitting multiple sclerosisStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
Appl Health Econ Health Policy 7:91-108. 2009..However, assessment of the cost effectiveness of NZ compared with other disease-modifying drugs in the presence of long-term data has been limited... - Model-based cost-effectiveness analyses for the treatment of acute stroke events: a review and summary of challengesStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, NC 27709 2194, USA
Value Health 12:507-20. 2009.... - Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysisS R Earnshaw
RTI Health Solutions, Research Triangle Park, NC 27709, USA
Aliment Pharmacol Ther 31:911-21. 2010..Opioid-induced constipation is a common adverse event in patients with advanced illness and has a significant negative impact on patients' quality of life and costs... - Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populationsStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
Pharmacoeconomics 28:489-505. 2010..Although 5-alpha reductase inhibitors (5ARIs) have demonstrated that they reduce the risk of prostate cancer (PCa), they have not demonstrated cost effectiveness in the patient populations in which they have been examined... - Cost-utility of aspirin and proton pump inhibitors for primary preventionStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
Arch Intern Med 171:218-25. 2011..Proton pump inhibitors (PPIs) may reduce upper GI bleeding. We estimate the cost-utility of aspirin treatment with or without a PPI for coronary heart disease (CHD) prevention among men at different risks for CHD and GI bleeding... - Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPDStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, NC, USA
Respir Med 103:12-21. 2009..We examine the lifetime cost-effectiveness of treatment with fluticasone propionate/salmeterol (500/50 microg) compared with no maintenance treatment in COPD in the US... - Integer/linear mathematical programming models: a tool for allocating healthcare resourcesStephanie R Earnshaw
RTI Health Solutions, Research Triangle Institute, North Carolina 27709, USA
Pharmacoeconomics 21:839-51. 2003.... - A cost-effectiveness analysis of antibiotic therapy in macrolide-resistant community-acquired pneumoniaStephanie R Earnshaw
Health Economics of RTI Health Solutions, Research Triangle Park, North Carolina 27709, USA
Manag Care Interface 18:36-44. 2005..Amoxicillin/ clavulanate ER resulted in a higher percentage of patients cured compared with clarithromycin ER (88.7% vs. 82.4%, respectively) and lower average per-patient treatment costs (dollar 437.70 vs. dollar 548.14, respectively)... - Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhageStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, NC, USA
Stroke 37:2751-8. 2006..In the current analysis, we examine the cost-effectiveness of early treatment with rFVIIa for ICH in the United States... - The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgetsStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, North Carolinar 27709, USA
Manag Care Interface 19:39-45. 2006..The implications for this sample health plan's budget are modest in the first year, and a reduction in costs is expected within three years owing to improved functional outcomes of patients... - A linear programming model for allocating HIV prevention funds with state agencies: a pilot studyStephanie R Earnshaw
RTI Health Solutions, RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
Health Care Manag Sci 10:239-52. 2007..We find that less efficient strategies, where 58% fewer infections are averted, result in significantly more equitable allocations. This tool serves as a guide for allocating funds for prevention activities... - Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in CanadaStephanie R Earnshaw
RTI Health Solutions, Research Triangle Park, North Carolina, USA
Clin Ther 29:2096-106; discussion 2094-5. 2007..Currently, there are no treatments available for the other AMD subtypes. Pegaptanib sodium was the first pharmacologic therapy approved in Canada for the treatment of subfoveal wet AMD regardless of subtype... - Allocating HIV prevention resources: a tool for state and local decision makingAnke Richter
Naval Postgraduate School, Monterey, CA, United States
Health Policy 87:342-9. 2008..By quantifying the impact of policy choices in terms of efficiency, cost, and distribution, the resource allocation tool makes the decision process more transparent and permits more informed choices...